3 Allergy, Pulmonary and Critical Care Medicine, Vanderbilt University School of Medicine, 1161 21st Avenue South T1218 MCN, Nashville, TN 37232-2650, USA. 4 Section of Anaesthetics, Pain Medicine, and Intensive Care, Imperial College London, Charing Cross Hospital, Fulham Palace Road The James Hogg iCAPTURE Centre for Cardiovascular and Pulmonary Research, 104 Bd Raymond Poincare. 8 Sirius Genomics Inc, 603-1125 Howe St, pp.166-1081, 2010. ,
Epidemiology of severe sepsis in the United States: Analysis of incidence, outcome, and associated costs of care, Critical Care Medicine, vol.29, issue.7, pp.291303-1310, 2001. ,
DOI : 10.1097/00003246-200107000-00002
Severe sepsis: a European estimate of the burden of disease in ICU [oral presentation abstract from 14th, Annual Congress of the European Society of Intensive Care Medicine, pp.27-284, 2001. ,
The Epidemiology of Sepsis in the United States from 1979 through 2000, New England Journal of Medicine, vol.348, issue.16, pp.1546-1554, 2000. ,
DOI : 10.1056/NEJMoa022139
Recombinant human protein C Worldwide Evaluation in Severe Sepsis (PROWESS) Study Group. Efficacy and safety of recombinant human activated protein C for severe sepsis, N Engl J Med, issue.10, pp.344699-709, 2001. ,
Assessing the Use of Activated Protein C in the Treatment of Severe Sepsis, New England Journal of Medicine, vol.347, issue.13, pp.1030-1034, 2002. ,
DOI : 10.1056/NEJMsb021512
CDER 2001 meeting documents. Transcript of Anti-Infective Drugs Advisory Committee Meeting Available from http, 2001. ,
Administration of Drotrecogin Alfa (Activated) in Early Stage Severe Sepsis (ADDRESS) Study Group. Drotrecogin alfa (activated) for adults with severe sepsis and a low risk of death, N Engl J Med, issue.13, pp.3531332-1341, 2005. ,
Researching Severe Sepsis and Organ Dysfunction in Children: A Global Perspective (RESOLVE) Study Group, Lancet, issue.9564, pp.369836-843, 2007. ,
International integrated database for the evaluation of severe sepsis (INDEPTH): clinical evaluation committee report on the safety of drotrecogin alfa (activated) therapy, Current Medical Research and Opinion, vol.24, issue.4, pp.1187-1197, 2008. ,
DOI : 10.1185/030079908X280563
Approval Letter, BLA#125029, Drotrecogin alfa (activated), Xigris.; Accessed 10, 2001. ,
Marketing authorization. European public assessment report, Drotrecogin alfa (activated), Xigris, 2002. ,
Design, conduct, analysis and reporting of a multi-national placebo-controlled trial of activated protein C for persistent septic shock, Intensive Care Med, issue.11, pp.341935-1947, 2008. ,
Genomics and drug response, N Engl J Med, vol.364, pp.1144-1153, 2011. ,
Vasopressin versus Norepinephrine Infusion in Patients with Septic Shock, New England Journal of Medicine, vol.358, issue.9, pp.877-887, 2008. ,
DOI : 10.1056/NEJMoa067373
Association study designs for complex diseases, Nature Reviews Genetics, vol.2, issue.2, pp.91-99, 2001. ,
DOI : 10.1038/35052543
Phosphatidylinositol 3,5-bisphosphanate (PI(3,5)P2) potentiates cardiac contractility via activation of the ryanodine receptor, J Biol Chem, issue.51, pp.28540312-40321, 2010. ,
Acinus is a caspase-3-activated protein required for apoptotic chromatin condensation, Nature, vol.401, issue.6749, pp.168-173, 1999. ,
Drotrecogin alfa (activated): real-life use and outcomes for the UK. Crit Care, p.58, 2008. ,
Use of Drotrecogin alfa (activated) in Italian intensive care units: the results of a??nationwide survey, Intensive Care Medicine, vol.29, issue.3, pp.426-434, 2007. ,
DOI : 10.1007/s00134-007-0554-x
A retrospective observational study of drotrecogin alfa (activated) in adults with severe sepsis: Comparison with a controlled clinical trial*, Critical Care Medicine, vol.36, issue.1, pp.14-23, 2008. ,
DOI : 10.1097/01.CCM.0000298309.73776.CB
Evaluating the use of Drotrecogin alfa (activated) in adult severe sepsis: a??Canadian multicenter observational study, Intensive Care Medicine, vol.31, issue.12 Suppl, pp.517-523, 2007. ,
DOI : 10.1007/s00134-007-0555-9
Drotrecogin alfa (activated), European Journal of Anaesthesiology, vol.25, issue.3, pp.211-216, 2008. ,
DOI : 10.1017/S0265021507002992
A REGISTRY OF PATIENTS TREATED WITH DROTRECOGIN ALFA (ACTIVATED) IN BELGIAN INTENSIVE CARE UNITS - AN OBSERVATIONAL STUDY, Acta Clinica Belgica, vol.27, issue.284, pp.25-30, 2008. ,
DOI : 10.1007/s00134-004-2157-0
Individual Matching with Multiple Controls in the Case of All-or-None Responses, Biometrics, vol.25, issue.2, pp.339-355, 1969. ,
DOI : 10.2307/2528794
Substantial Gains in Bias Reduction from Matching with a Variable Number of Controls, Biometrics, vol.27, issue.1, pp.118-124, 2000. ,
DOI : 10.1111/j.0006-341X.2000.00118.x
Constructing a control group using multivariate matched sampling methods that incorporate the propensity score, Am Stat, vol.39, issue.1, pp.33-38, 1985. ,
Drotrecogin alfa (activated) administration across clinically important subgroups of patients with severe sepsis, Critical Care Medicine, vol.31, issue.1, pp.3112-3131, 2003. ,
DOI : 10.1097/00003246-200301000-00002
Incidence and Outcomes of Acute Lung Injury, New England Journal of Medicine, vol.353, issue.16, pp.1685-1693, 2005. ,
DOI : 10.1056/NEJMoa050333
for the National Heart, Lung, and Blood Institute Acute Respiratory Distress Syndrome Network: A simple clinical predictive index for objective estimates of mortality in acute lung injury, Crit Care Med, issue.16, pp.371913-1920, 2009. ,
Diagnosis and Treatment of Acute Tubular Necrosis, Annals of Internal Medicine, vol.137, issue.9, pp.744-752, 2002. ,
DOI : 10.7326/0003-4819-137-9-200211050-00010
Acute Renal Failure and Sepsis, New England Journal of Medicine, vol.351, issue.2, pp.159-169, 2004. ,
DOI : 10.1056/NEJMra032401
Thrombocytopenia and prognosis in intensive care, Critical Care Medicine, vol.28, issue.6, pp.1871-1876, 2000. ,
DOI : 10.1097/00003246-200006000-00031
Platelet function in sepsis, Critical Care Medicine, vol.30, issue.Supplement, pp.313-317, 2002. ,
DOI : 10.1097/00003246-200205001-00022
APACHE II, Critical Care Medicine, vol.13, issue.10, pp.818-829, 1985. ,
DOI : 10.1097/00003246-198510000-00009
A New Simplified Acute Physiology Score (SAPS II) Based on a European/North American Multicenter Study, JAMA: The Journal of the American Medical Association, vol.270, issue.24, pp.2957-2963, 1993. ,
DOI : 10.1001/jama.1993.03510240069035
Severe community-acquired pneumonia as a cause of severe sepsis: Data from the PROWESS study*, Critical Care Medicine, vol.33, issue.5, pp.952-961, 2005. ,
DOI : 10.1097/01.CCM.0000162381.24074.D7
Controlling Bias in Observational Studies: A Review, Indian J Stat, vol.35, issue.4, pp.417-446, 1973. ,
DOI : 10.1017/CBO9780511810725.005
Comparison of multivariate matching methods: structures, distances, and algorithms, J Computational Graphical Statistics, vol.4, pp.405-420, 1993. ,
A critical appraisal of propensity-score matching in the medical literature between 1996 and 2003, Statistics in Medicine, vol.26, issue.1, pp.2037-2049, 1996. ,
DOI : 10.1002/sim.3150
Ancestry informative marker sets for determining continental origin and admixture proportions in common populations in America, Human Mutation, vol.118, issue.1, pp.69-78, 2009. ,
DOI : 10.1002/humu.20822
An ancestry informative marker set for determining continental origin: validation and extension using human genome diversity panels, BMC Genetics, vol.10, issue.1, p.39, 2009. ,
DOI : 10.1186/1471-2156-10-39
URL : http://doi.org/10.1186/1471-2156-10-39